Hainan Community Cognition Cohort
A Prospective Cohort of Hainan Community Elderly Population with Cognitive Impairment
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Jindong Ding Petersen, PHD.
- Phone Number: 089866893772
- Email: dingjindong@muhn.edu.cn
Study Locations
-
-
Hainan
-
Haikou, Hainan, China, 571199
- Recruiting
- Hainan Medical University
-
Contact:
- Jindong Ding Petersen, PHD
- Phone Number: +8613256406001
- Email: dingjindong@muhn.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 60 years and above
- Lived in the community for more than 6 months
- Signed the informed consent form
Exclusion Criteria:
- Cannot complete the survey
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The prevalence and incidence of cognitive impairment base on the communities
Time Frame: An average of 1 to 2 years
|
Mild cognitive impairment was measured using a Chinese version Mini-Mental State Examination, which was collected by questionnaire.
The minimum value of the Mini-Mental State Examination is 0, and the maximum value is 30, the higher the score, the better the cognition outcome.
|
An average of 1 to 2 years
|
|
The prevalence and incidence of dementia using a population-based survey
Time Frame: An average of 1 to 2 years
|
Dementia was determined by diagnosis of hospitalization or Clinical Dementia Rating Scale (Montreal Cognitive Assessment, MoCA). The minimum value of the MoCA is 0, and the maximum value is 30, the higher the score, the better the outcome. In addition, subtypes of dementia will be based on the specific clinical diagnosis. |
An average of 1 to 2 years
|
|
The conversion rate of normal to cognitive impairment
Time Frame: An average of 1 to 2 years
|
Percentage of enrolled population that convert from normal to cognitive impairment
|
An average of 1 to 2 years
|
|
The conversion rate of cognitive impairment to dementia
Time Frame: An average of 1 to 2 years
|
Percentage of enrolled population that convert from cognitive impairment to dementia
|
An average of 1 to 2 years
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Hainan Medical University
- ZDYF2024SHFZ064 (Other Grant/Funding Number: Hainan Provincial Department Of Science and Technology)
- 82360673 (Other Grant/Funding Number: National Natural Science Foundation of China)
- XRC2022005 (Other Grant/Funding Number: Hainan Medical University)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.